Poseida Therapeutics, Inc. earnings per share and revenue

PSTX earnings per share for the last quarter are 0.21 USD whereas the estimation was -0.42 USD which accounts for 150.30% surprise. Company revenue for the same period amounts to 71.75 M USD despite the estimated figure of 16.25 M USD. Estimated earnings per share for the next quarter are -0.35 USD, and revenue is expected to reach 21.25 M USD. Also watch annual changes over time to get a bigger picture of PSTX earnings per share and revenue dynamics.